 |
|
|
|
 |
|||
Independence has been a buzzword in corporate governance circles for some time now. That doesn’t mean everyone is on board, of course: Over at BioMed Realty Trust (BMR), directors decided that, in the end, best practices might not be best after all. The news came on June 2, in a grab-bag of an 8-K that [...]
There are several good articles today (such as this one and that one) about the executive compensation changes and the NEOs’ personal plane usage at Ford Motor Co. (F), so there’s no need to rehash either of those subjects. Instead, the topic that caught our attention in the preliminary proxy that Ford filed this morning [...]
One of the more popular posts we’ve done here at footnoted — at least in terms of reader comments — was this one from two years ago on the lack of adequate products at a Rite Aid (RAD) store in Manhattan. Even after all this time, Rite Aid employees still write in to grouse about [...]
Last week, we wrote about the new book, Money for Nothing which takes a hard look at directors of publicly traded companies. On Friday, we came across Exhibit A for the authors when we caught this proxy filed by Bway Holding (BWY), an Atlanta-based company we’re guessing most people aren’t too familiar with, given its [...]
We’ve been skeptical about the deal between Xerox and ACS ever since it was announced on Sept. 28. As we wrote over on Research Edge last month, after the S-4 was filed, this seemed like an awfully good deal for ACS Chairman Darwin Deason and a few other top executives at ACS “and nothing all [...]
